Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
25%
Ph early_phase_1
2
25%
Ph phase_2
2
25%
Ph not_applicable
1
13%
Ph phase_3
1
13%

Phase Distribution

4

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Early Phase 1First-in-human
2(25.0%)
Phase 1Safety & dosage
2(25.0%)
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

8

all time

Status Distribution
Active(4)
Completed(3)
Terminated(1)

Detailed Status

Completed3
Not yet recruiting2
Withdrawn1
Active, not recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
2
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 12 (25.0%)
Phase 12 (25.0%)
Phase 22 (25.0%)
Phase 31 (12.5%)
N/A1 (12.5%)

Trials by Status

completed338%
withdrawn113%
active_not_recruiting113%
not_yet_recruiting225%
recruiting113%

Recent Activity

2 active trials
Showing 5 of 8
not_yet_recruitingearly_phase_1

Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia

NCT07612605
recruitingphase_3

Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

NCT06870409
not_yet_recruitingearly_phase_1

A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli

NCT07338123
active_not_recruitingphase_1

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

NCT05182749
withdrawnphase_2

Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

NCT05269134
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07612605Early Phase 1

Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia

Not Yet Recruiting
NCT06870409Phase 3

Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

Recruiting
NCT07338123Early Phase 1

A Randomized Controlled Trial (RCT) of Yiqi Huoxue Jiedu Formula Combined With Bacteriophages in the Treatment of Severe Pneumonia Caused by Drug-resistant Gram-negative Bacilli

Not Yet Recruiting
NCT05182749Phase 1

Safety and Efficacy of the Bacteriophage Preparation, ShigActive™, in a Human Experimental Model of Shigellosis

Active Not Recruiting
NCT05269134Phase 2

Bacteriophage Therapy in Patients With Prosthetic Joint Infections (PJI)

Withdrawn
NCT04325685Not Applicable

The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia

Completed
NCT00663091Phase 1

A Prospective, Randomized, Double-Blind Controlled Study of WPP-201 for the Safety and Efficacy of Treatment of Venous Leg Ulcers

Completed
NCT00001145Phase 2

Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8